MM-153 Phase 2 CARTITUDE-2 Study (Cohort B): Updated Clinical Data and Biological Correlative Analyses of Ciltacabtagene Autoleucel (cilta-cel), a BCMA-Directed CAR-T Cell Therapy, in Patients With Multiple Myeloma (MM) and Early Relapse After Initial Therapy
Mounzer Agha, Niels WCJ Van de Donk, Adam D. Cohen, Yael C. Cohen, Sébastien Anguille, Tessa Kerre, Wilfried Roeloffzen, Jordan M. Schecter, Kevin C. de Braganca, Helen Varsos, Pankaj Mistry, Tito Roccia, Enrique Zudaire, Christina Corsale, Muhammed Akram, Dong Geng, Tonia Nesheiwat, Lida Pacaud, Pieter Sonneveld, Sonja Zweegman
Research output: Contribution to journal › Article › peer-review
1Scopus
citations
Fingerprint
Dive into the research topics of 'MM-153 Phase 2 CARTITUDE-2 Study (Cohort B): Updated Clinical Data and Biological Correlative Analyses of Ciltacabtagene Autoleucel (cilta-cel), a BCMA-Directed CAR-T Cell Therapy, in Patients With Multiple Myeloma (MM) and Early Relapse After Initial Therapy'. Together they form a unique fingerprint.